CBD SCIENCE

Welcome to the Brand page for “CBD SCIENCE”, which is offered here for Pharmaceutical preparations for the treatment of pain, disease, illness, and injury; pharmaceutical preparations for the treatment of neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, and metabolic disorders; pharmaceutical preparations for use in oncology; pharmaceutical preparations for therapeutic purposes in the treatment of pain, disease, illness, and injury; pharmaceutical preparations for the treatment of mental illness; dietary supplements; all of the foregoing containing cbd solely derived from hemp with a delta-9 tetrahydrocannabinol (thc) concentration of not more than 0.3 percent on a dry weight basis;.

Its status is currently believed to be active. Its class is unavailable. “CBD SCIENCE” is believed to be currently owned by “Boston Research & Development, LLC”.


Owner:
BOSTON RESEARCH & DEVELOPMENT, LLC
Owner Details
Description:
Pharmaceutical preparations for the treatment of pain, disease, illness, and injury; pharmaceutical preparations for the treatment of neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, and metabolic disorders; pharmaceutical preparations for use in oncology; pharmaceutical preparations for therapeutic purposes in the treatment of pain, disease, illness, and injury; pharmaceutical preparations for the treatment of mental illness; dietary supplements; all of the foregoing containing CBD solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis;
Categories: PHARMACEUTICAL PREPARATIONS TREATMENT